You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 The susceptibilities of ESBL-screen positive Escherichia coli and Klebsiella pneumoniae strains isolated from HA and CA IAIs

From: Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients

  Escherichia coli, ESBL+ Klebsiella pneumoniae, ESBL+
HA% CA% HA% CA%
Amikacin 91.46 89.47 86.17 80.25
Piperacillin Tazobactam 85.73 88.72 67.37 66.67
Ampicillin Sulbactam 4.70 5.76 3.19 2.47
Imipenem 97.84 96.74 84.40 80.25
Ertapenem 92.02 91.98 77.66 71.61
Cefoxitin 65.63 67.42 59.58 45.68
Ceftazidime 33.80 37.09 36.17 25.93
Cefepime 4.60 4.76 8.51 4.94
Ceftriaxone 0.75 0.75 1.77 0.00
Cefotaxime 0.47 0.00 1.06 1.23
Levofloxacin 19.91 22.56 50.00 49.38
Ciprofloxacin 17.09 18.04 36.17 33.33